Published reviews of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) for facial skin report mixed results, and none of the review abstracts we read isolates the vampire facial protocol. The 2020 review states that the persistence of its effects is not known.
The Centers for Disease Control and Prevention (CDC) documented confirmed human immunodeficiency virus (HIV) cases presumptively linked to cosmetic PRP microneedling at an unlicensed spa.
Does a Vampire Facial Work?
The research base evaluates PRP and PRF preparations used across facial rejuvenation, but it does not isolate platelet concentrate applied specifically with microneedling.
The available systematic reviews show varied outcomes across specific skin parameters. While some studies report measurable gains in skin thickness and elasticity, outcomes for wrinkles, skin texture and pigmentation remain inconsistent.
In 2024, the CDC published an investigation of an unlicensed New Mexico spa. In it, 4 of the 20 clients who received PRP microneedling, plus 1 sexual partner who received no spa services, were confirmed with HIV infections presumptively linked to the spa. That investigation identified unsafe infection-control practices, but it provides no infection rate for licensed clinical facilities.
In the 510(k) clearance summaries we reviewed from the Food and Drug Administration (FDA), the devices reviewed are cleared for bone-graft handling.
What a Vampire Facial Is
A vampire facial is the popular name for an autologous PRP microneedling facial. The procedure begins with a blood draw from the patient, followed by processing the blood in a centrifuge to separate and concentrate platelets in the plasma. A provider then applies this autologous platelet concentrate across the face using microneedling, which uses tiny needles to prick the skin.
Platelet-rich fibrin (PRF) is a related blood-derived preparation. You can review the structural differences between these preparations in our guide to PRP vs PRF.
An exosome facial is a separate product. To understand how these treatments sit within the wider cosmetic market, read our guide to regenerative medicine in dermatology.
What Reviews of PRP and PRF for Facial Skin Report
The clinical literature on autologous blood concentrates for facial skin consists of systematic reviews pooling heterogeneous studies. None of the review abstracts isolates PRP applied with microneedling as a standalone category.
In 2020, Maisel-Campbell and colleagues published a systematic review in Archives of Dermatological Research examining the safety and effectiveness of PRP for skin aging. The authors evaluated 24 studies representing 480 patients who received PRP, including 8 randomized controlled trials. That review evaluated PRP injection as a monotherapy rather than microneedling delivery.
The 2020 review concluded that PRP monotherapy at least temporarily induced modest improvements in facial appearance, skin texture and lines according to physician global assessments. Most reported improvements remained under 50%, though patients generally reported high satisfaction. The authors described PRP as safe and potentially modestly beneficial, noting the most convincing results occurred in facial skin texture. The authors emphasized that the persistence of these effects is not known and noted significant limitations caused by varied preparation methods and outcome measures across studies.
In 2025, a second systematic review in Annals of Plastic Surgery examined 20 articles covering 514 patients receiving PRP and PRF for facial rejuvenation. The authors pooled PRP and PRF data and stated that clinical effectiveness remains controversial, with studies yielding mixed results.
The share of studies reporting significant improvement, by skin measure, in the 2025 review:
- Wrinkles and fine lines: 40% of 16 studies
- Pigmentation (dyschromia): 17% of 12 studies
- Skin texture: 33% of 11 studies
- Elasticity: 75% of 6 studies
- Skin thickness: 80% of 5 studies (4 of 5)
- Hydration: 0% of 4 studies
All studies in the 2025 review that measured patient satisfaction reported improvement, and no serious adverse events were reported in the included studies. The abstract of this review does not report how long the effects last.
Because neither abstract isolates microneedling combined with PRP from other delivery methods, the reported rates in the list above do not confirm how PRP performs when applied with microneedling.
What the CDC Found at a New Mexico Spa
On April 25, 2024, the CDC published an investigation in the Morbidity and Mortality Weekly Report detailing presumptive HIV transmission associated with PRP microneedling facials at an unlicensed spa in New Mexico. The facials were received in 2018, and the diagnoses were reported from 2018 to 2023.
Public health investigators identified 59 spa clients considered at risk. Of those 59 individuals, 20 had received PRP microneedling facials and 39 had received other cosmetic injection services, such as botulinum toxin.
The investigation confirmed spa-related HIV infections in five people:
- Four women who were among the 20 clients who received PRP microneedling facials
- One man who was the sexual partner of one of those four women and had never received any spa services
Investigators tested 198 former clients and partners. Testing identified no additional HIV infections, and no hepatitis B or hepatitis C infections were found among the tested population.
A fall 2018 state inspection uncovered unsafe infection-control practices. Inspectors found blood collection tubes and a centrifuge sitting on a kitchen counter, and they found blood and injectable products stored with food. Inspectors also found unwrapped syringes. The facility had no autoclave steam sterilizer on site.
Inspectors also discovered that disposable electric desiccator tips were cleaned by alcohol immersion and then reused. The spa owner operated without appropriate licenses.
The CDC report explicitly outlines several investigative limitations:
- Transmission is classified as presumptive rather than definitively observed.
- The precise source of viral contamination inside the facility remains unknown.
- Investigators were not permitted to collect specimens at the spa.
- Case linkage was established through viral sequence similarity among patient blood samples.
The CDC report concerns an unlicensed spa. It gives no infection rate for licensed clinics. The report concludes that healthcare providers might consider cosmetic injection services as a potential transmission route when assessing patients who lack other HIV risk factors. The report says requiring adequate infection control at spas that offer injection services can help prevent bloodborne infections, and that keeping client records could help investigations.
What FDA Clearance Summaries Say About PRP Devices
In the FDA clearance summaries we reviewed, BK241083 and BK230807 are Class II devices whose indications mix the PRP with bone graft material.
In FDA 510(k) summary BK241083 for the OrthoAscent FG-001 Platelet Rich Plasma Device, prepared September 5, 2024, the device is classified as a “Platelet And Plasma Separator For Bone Graft Handling.” The regulatory summary states:
“The PRP prepared by this device has not been evaluated for any clinical indications. The PRP prepared by this device is NOT indicated for delivery to the patient’s circulatory system.”
The clearance summary states that the product is indicated to be mixed with autograft or allograft bone before application to an orthopedic surgical site to improve handling characteristics.
Similarly, in FDA 510(k) summary BK230807 for the Genesis Biologics Adaptive Autologous Processing System, prepared May 9, 2023, the device is Class II under 21 CFR 864.9245. The summary gives its classification name as “Automated blood cell separator” and its common name as “Platelet and Plasma Separator for Bone Graft Handling”. The cleared indication specifies:
“…the safe and rapid preparation of autologous platelet-rich plasma (PRP) from a small sample of peripheral blood at the patient point-of-care. The PRP is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.”
We did not find a facial-skin indication in either summary.
You can learn more about how federal oversight applies across autologous preparations in our guide to FDA status in regenerative medicine. You can also read our PRP therapy overview.
Who Should Skip a Vampire Facial
Skip a vampire facial if you cannot confirm the provider’s license and sterile, single-use equipment.
Patients expecting a dramatic result should skip the treatment. In the 2025 review, 40% of 16 wrinkle studies and 17% of 12 pigmentation studies reported significant improvement.
No official FDA contraindication list was found in the sources reviewed for this page. Individuals with a blood or skin condition should ask their own clinician before scheduling treatment.
What Would Change This Answer
This answer would change if researchers complete large, randomized controlled trials that directly compare microneedling with PRP against microneedling alone using standardized preparation kits and objective, long-term outcome measures. An FDA clearance or approval of a PRP device or product for facial rejuvenation would also change this answer.
Questions to Ask Before Booking
If you evaluate a clinic offering PRP microneedling services, verify safety, credentials and equipment before paying. Request written responses to these six questions:
- Who holds the medical license overseeing the clinic, and what specific professional license does the person performing the blood draw and microneedling hold?
- Will all blood collection tubes, processing kits, syringes and microneedling tips be opened from sealed, sterile, single-use packaging directly in front of you?
- What exact written protocol does the facility follow for centrifuging blood, and how many treatment sessions does the proposed aesthetic plan include?
- What is the total written price for the whole protocol?
- What clinical claims does the clinic make regarding skin rejuvenation outcomes, and has the specific PRP preparation system received FDA clearance or approval for facial skin use?
- How does the facility handle client records, adverse event management, biological waste disposal and sanitation between patient appointments?
To understand broader procedural pricing across autologous therapies, review our PRP injection cost guide. For a complete list of administrative red flags, review our guide on how to vet a clinic.
Bottom Line for Buyers
For adults weighing an autologous blood treatment for facial skin, the procedure represents an unproven cosmetic expense supported by small, mixed studies that do not isolate microneedling delivery. The CDC linked confirmed HIV infections to PRP microneedling facials at an unlicensed spa with unsafe infection-control practices, and it reported no infection rate for licensed clinics. The CDC says the source of the contamination is unknown.
Skip the procedure if you cannot confirm the provider’s license and sterile, single-use equipment, or if you expect a dramatic result. Anyone with a blood or skin condition should ask their own clinician.
Compare the clinic against our red-flags checklist on how to vet a clinic before you book a vampire facial.
Frequently asked questions
Is a vampire facial safe?
The Centers for Disease Control and Prevention (CDC) reported confirmed HIV infections presumptively linked to PRP microneedling facials at an unlicensed New Mexico spa with unsafe infection-control practices. The report gives no infection rate for licensed clinics, and a 2025 systematic review in Annals of Plastic Surgery reported no serious adverse events in its included facial rejuvenation studies.
Does a vampire facial work?
Published clinical evidence on whether a vampire facial works remains limited and mixed, and none of the review abstracts we read isolates platelet-rich plasma applied with microneedling. In a 2025 review in the Annals of Plastic Surgery, the share of studies reporting significant improvement was 80% of 5 for skin thickness and 75% of 6 for elasticity, but 40% of 16 for wrinkles, 33% of 11 for texture, and 17% of 12 for pigmentation. The 2020 review states that the persistence of the effects is not known.
Can PRP reduce smile lines?
The sources reviewed here do not isolate smile lines. In a 2025 systematic review of PRP and PRF for facial rejuvenation, 40% of the 16 studies that evaluated wrinkles and fine lines reported significant improvement.
How long do vampire facial results last?
How long effects last is unknown. The 2020 systematic review in Archives of Dermatological Research notes that the persistence of effects is not known, and the abstract of the 2025 Annals of Plastic Surgery review does not report how long effects last.
What is the downside of a vampire facial?
The downsides are that the clinical evidence is small and mixed without isolating PRP applied with microneedling. The most serious documented harm comes from a CDC report of confirmed HIV infections presumptively linked to PRP microneedling facials at an unlicensed New Mexico spa with unsafe infection-control practices. That investigation focused on an unlicensed facility and gives no infection rate for licensed clinics.
Who is not a good candidate for a vampire facial?
No Food and Drug Administration (FDA) contraindication list was found in the sources reviewed for this page. Anyone who cannot verify a provider's professional license, sterile equipment and single-use supplies should skip the procedure. Patients with an underlying blood or skin condition should consult their own clinician.
Is a vampire facial the same as microneedling?
No. Microneedling is the use of tiny needles to prick the skin. A vampire facial is the popular name for a procedure that combines microneedling with the application of autologous platelet-rich plasma concentrated from the patient's blood.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.